Hi Kevin,
I saw your message yesterday and I emailed the contact I have at Dizal.
This was the exact response I received this morning (see below). Frustrating, I know!
Dear Stefanie,
We appreciate your follow-up. Right now, we are actively working to establish the necessary infrastructure and processes to make the drug available through appropriate channels. While we do not yet have specific timelines or details to share, this remains a high priority for our team, and we are committed to keeping you informed as progress is made. We sincerely appreciate your patience and understanding as we navigate this transition.
With best regards,
Sadashiva Swamy
Sr. Global Study Leader
T: + 86 21 6109 5842